Secukinumab Fails to Show Benefit in Graves' Orbitopathy

Secukinumab does not show greater clinical efficacy than placebo in patients with moderate-to-severe Graves’ orbitopathy, according to the ORBIT study.
Medscape News UK

Source link : https://www.medscape.com/viewarticle/secukinumab-fails-show-benefit-graves-orbitopathy-2025a1000yyx?src=rss

Author :

Publish date : 2025-12-16 12:00:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Secukinumab Fails to Show Benefit in Graves’ Orbitopathy

Risk-Based Early-Term Birth Cuts Preeclampsia Risk

Do Fertility Treatments Raise Heart Disease Risks in Women?

Related Posts

‘A Fiasco’; Diabetes Drugs and GI Cancer Risk; New Guidelines on Liver Transplants

Establishing Connection and Trust With Breast Cancer Patients

How Often Does Dry Needling Lead to a Collapsed Lung?

Adult Congenital Heart Docs Should Be More Involved, Says New Guideline

Two asteroids crashed around a nearby star, solving a cosmic mystery

Precision Medicine in Sjogren’s Disease

‘A Fiasco’; Diabetes Drugs and GI Cancer Risk; New Guidelines on Liver Transplants

Establishing Connection and Trust With Breast Cancer Patients

How Often Does Dry Needling Lead to a Collapsed Lung?

Adult Congenital Heart Docs Should Be More Involved, Says New Guideline

Two asteroids crashed around a nearby star, solving a cosmic mystery

Precision Medicine in Sjogren’s Disease

Orforglipron Helps Maintain Weight Loss After Injectables

Meningioma Warning Added to Depo-Provera Label

Categories

Archives